Vector Lifting Radiesse

Nowadays, injections of the volumizing filler Radiesse Volumizing Filler (Merz Pharma, Germany) are used to restore lost tissue volume in the middle and lower thirds of the face, as well as to lift thin and loose skin.
The base of Radiesse consists of calcium hydroxyapatite microspheres and a gel as its carrier. Calcium hydroxyapatite is a natural component of tooth enamel and bone tissue. For use in cosmetology, the substance is artificially synthesized in laboratories and produced as a suspension with a water gel.
The uniqueness of Radiesse lies in the fact that 1.5-2 months after the procedure, the gel dissolves (absorbed by macrophage cells), but the calcium hydroxyapatite microspheres continue to remain in the tissues, stimulating the growth of natural collagen. Thus, a new dermal matrix is formed, which structurally supports the tissues at the appropriate level and prevents sagging. This process continues for several months, enhancing the initial effect.
The main advantages of Radiesse volumizer over hyaluronic fillers are the duration of the effect (1.5 – 2 years) and the complete absence of swelling. Radiesse is ideal for patients who are prone to swelling and have a puffy face effect after correction with hyaluronic fillers.
INDICATIONS FOR RADIESSE USE.
- Vector lifting of the middle and lower third of the face;
- Elimination of nasolabial folds;
- Correction of marionette lines;
- Volumization of the cheekbone area;
- Modeling of the face oval;
- Templating of the temporal area;
- Chin correction;
- Rejuvenation of hands;
- Elimination of neck and décolleté skin laxity.
SIDE EFFECTS. Immediately after the procedure, temporary redness at the injection site, hematoma, or hardening may occur.
CONTRAINDICATIONS.
- Pregnancy, lactation period;
- Oncological diseases;
- Use of anticoagulants;
- Presence of inflammation or infection at the procedure site;
- Tendency to form scars;
- Hemophilia (blood clotting disorder);
- Diabetes.
Copying this text without a link to the source is prohibited.


| Vector Lifting Radiesse | ||
| Radiesse (1.5 ml, syringe) | 11000 | 1.5 hours |

Nowadays, injections of the volumizing filler Radiesse Volumizing Filler (Merz Pharma, Germany) are used to restore lost tissue volume in the middle and lower thirds of the face, as well as to lift thin and loose skin.
The base of Radiesse consists of calcium hydroxyapatite microspheres and a gel as its carrier. Calcium hydroxyapatite is a natural component of tooth enamel and bone tissue. For use in cosmetology, the substance is artificially synthesized in laboratories and produced as a suspension with a water gel.
The uniqueness of Radiesse lies in the fact that 1.5-2 months after the procedure, the gel dissolves (absorbed by macrophage cells), but the calcium hydroxyapatite microspheres continue to remain in the tissues, stimulating the growth of natural collagen. Thus, a new dermal matrix is formed, which structurally supports the tissues at the appropriate level and prevents sagging. This process continues for several months, enhancing the initial effect.
The main advantages of Radiesse volumizer over hyaluronic fillers are the duration of the effect (1.5 – 2 years) and the complete absence of swelling. Radiesse is ideal for patients who are prone to swelling and have a puffy face effect after correction with hyaluronic fillers.
INDICATIONS FOR RADIESSE USE.
- Vector lifting of the middle and lower third of the face;
- Elimination of nasolabial folds;
- Correction of marionette lines;
- Volumization of the cheekbone area;
- Modeling of the face oval;
- Templating of the temporal area;
- Chin correction;
- Rejuvenation of hands;
- Elimination of neck and décolleté skin laxity.
SIDE EFFECTS. Immediately after the procedure, temporary redness at the injection site, hematoma, or hardening may occur.
CONTRAINDICATIONS.
- Pregnancy, lactation period;
- Oncological diseases;
- Use of anticoagulants;
- Presence of inflammation or infection at the procedure site;
- Tendency to form scars;
- Hemophilia (blood clotting disorder);
- Diabetes.
Copying this text without a link to the source is prohibited.
